Atorvastatin Calcium
Product Images NDC 60760-709

5 FDA label images from St. Mary's Medical Park Pharmacy · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 60760-709). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

At] (Atorvastatin 60760 709 30)

At] (Atorvastatin 60760 709 30)
Atorvastatin Calcium Tablets, USP 40 mg label showing a quantity of 30 tablets. The product is manufactured by Alkem Laboratories Ltd., Mumbai, India and packaged by St. Mary's Medical Park Pharmacy, Oro Valley, AZ. The label includes sections for lot number, expiration date, and Rx number, all indicated as unknown or placeholders. Storage instructions recommend controlled room temperature (15°-30°C).*
FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

Atorvastatin-fig-1 (Atorvastatin Fig 1)
A line graph comparing the cumulative incidence percentage over time in years for Atorvastatin and Placebo groups. The graph shows lower incidence for Atorvastatin with hazard ratio HR=0.64 (0.50-0.83) and p-value 0.0005.*
FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

Atorvastatin-fig-2 (Atorvastatin Fig 2)
A line graph comparing cumulative hazard percentage over time (years) for Atorvastatin versus placebo. The x-axis shows time to first primary endpoint through four years of follow-up, and the y-axis shows cumulative hazard percentage. The graph includes hazard ratio (HR 0.63) and p-value (0.001) indicating statistical comparison between groups.*
FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

Atorvastatin-fig-3 (Atorvastatin Fig 3)
A line chart displaying the percentage of subjects experiencing an event over time, comparing Atorvastatin 10 mg (dashed line) and Atorvastatin 80 mg (solid line). The x-axis shows time to first major cardiovascular endpoint in years (0 to 5), and the y-axis shows the percentage of subjects experiencing an event (0 to 0.2%). The chart includes a hazard ratio (HR) of 0.78 with 95% confidence interval (0.69-0.89) and a p-value of 0.0002.*
FDA Label Image

Atorvastatin-st (Atorvastatin St)

Atorvastatin-st (Atorvastatin St)
Chemical structure of Atorvastatin Calcium, showing the molecular arrangement including multiple benzene rings, fluorine atom, hydroxyl groups, and calcium ion with hydration indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.